Myriad Genetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A.

CEO

Samraat S Raha

CEOSamraat S Raha

Employees

2,700

Employees2,700

Headquarters

Salt Lake City, Utah

HeadquartersSalt Lake City, Utah

Founded

1991

Founded1991

Employees

2,700

Employees2,700

MYGN Key Statistics

Market cap

496.86M

Market cap496.86M

Price-Earnings ratio

-1.29

Price-Earnings ratio-1.29

Dividend yield

—

Dividend yield—

Average volume

3.40M

Average volume3.40M

High today

$5.70

High today$5.70

Low today

$5.23

Low today$5.23

Open price

$5.44

Open price$5.44

Volume

777.58K

Volume777.58K

52 Week high

$29.30

52 Week high$29.30

52 Week low

$3.76

52 Week low$3.76

MYGN News

TipRanks 12h

ANGLE plc Collaborates with Myriad Genetics to Enhance Cancer Diagnostics

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 1d

Myriad Genetics reaffirms FY25 guidance

On Monday, Myriad reaffirmed its financial guidance for the full-year 2025, as announced during its second quarter 2025 earnings call on August 5, 2025. Myriad...

Seeking Alpha 2d

Myriad Genetics announces CFO appointment

Healthcare Myriad Genetics announces CFO appointment Aug. 18, 2025 8:43 AM ET Myriad Genetics, Inc. (MYGN) Stock By: Khushi Singh, SA News Editor 5 Share Save...

Analyst ratings

53%

of 15 ratings

Buy

20%

Hold

53.3%

Sell

26.7%

People also own

Based on the portfolios of people who own MYGN. This list is generated using Robinhood data, and it’s not a recommendation.